UnicoCell Biomed Co (TPE:6794) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 09, 2026)


TPE:6794 UnicoCell Biomed Co Ltd TPE:6794
83 GF Score
Price NT$82.30
GF Value NT$101.61
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is UnicoCell Biomed Co Float Percentage Of Total Shares Outstanding?

UnicoCell Biomed Co TPE:6794 -3.40% 83 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 09, 2026. GuruFocus rates TPE:6794 with a GF Score™ of 83/100 and a GF Value™ of NT$101.61 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, UnicoCell Biomed Co's float shares is 0.00 Mil. UnicoCell Biomed Co's total shares outstanding is 63.64 Mil. UnicoCell Biomed Co's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, UnicoCell Biomed Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, UnicoCell Biomed Co's Institutional Ownership is 0.00%.

TPE:6794
83GF Score
UnicoCell Biomed Co Ltd TPE:6794
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UnicoCell Biomed Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

UnicoCell Biomed Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/63.64
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
UnicoCell Biomed Co (TPE:6794) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 09, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on UnicoCell Biomed Co and its competitors.
Is UnicoCell Biomed Co's Float Percentage Of Total Shares Outstanding too high?
UnicoCell Biomed Co's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, UnicoCell Biomed Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UnicoCell Biomed Co's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
UnicoCell Biomed Co's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on UnicoCell Biomed Co and its competitors. UnicoCell Biomed Co's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnicoCell Biomed Co stock overvalued right now?
Based on GuruFocus' analysis, UnicoCell Biomed Co (TPE:6794) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$101.61, compared to a current price of NT$82.30 — trading 19% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. UnicoCell Biomed Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For UnicoCell Biomed Co (TPE:6794), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UnicoCell Biomed Co (TPE:6794) Overvalued in 2026?

Based on GuruFocus' analysis, UnicoCell Biomed Co stock appears to be undervalued. The current stock price of NT$82.30 is trading 19% below its estimated GF Value™ of NT$101.61. GuruFocus considers UnicoCell Biomed Co to be Modestly Undervalued.

Key valuation signals for TPE:6794:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: NT$101.61 vs. price of NT$82.30 (19% below fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the TPE:6794 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UnicoCell Biomed Co Business Description

Address Minquan East Road, 5th Floor, No. 13-20, Section 6, Neihu District, Taipei, TWN, 11494
UnicoCell Biomed Co Ltd is engaged in new drug R&D and human tissue-derived stem cell inspection and testing, extraction, storage, and technology R&D. It focuses on researching and developing stem cells and its derived technology for medical applications, with the goal of advancing human health and improving quality of life. The company's products include Allogeneic Adipose Stem Cell Bank, Autologous Stem Cell Therapy, Conditioned Medium, Mass Production and CDMO, Cryogenic Vial (Class 2 Medical Device), and Testing services. It operates in single segment. Geographically, its operations are spread across Taiwan, Japan and Others with Taiwan generating the majority of the revenue.
83GF Score

Get the complete analysis for TPE:6794

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$82.30
Price
NT$101.61
GF Value